Related by context. All words. (Click for frequent words.) 71 univariate 70 Logistic regression 70 covariate 69 Multiple logistic regression 68 conditional logistic regression 67 Descriptive statistics 67 logistic regressions 67 Poisson regression 67 multivariable logistic regression 67 bivariate 66 logistic regression model 66 logistic regression analyzes 66 multivariate logistic regression 66 Multiple linear regression 66 logistic regression analysis 66 multiple logistic regression 66 Multivariate logistic regression 66 multiple linear regression 65 logistic regression 65 multivariate analyzes 65 differentially expressed genes 65 logistic regression models 65 regression analyzes 65 univariate analyzes 64 sociodemographic variables 64 APOE genotype 64 etiologic 64 meta analytic 64 generalized estimating 64 covariance 64 multivariate regression 64 genotype phenotype 64 Univariate 63 multivariate Cox 63 alexithymia 63 interobserver 63 Univariate analysis 63 odds ratios ORs 62 clinicopathological 62 multivariable Cox 62 meta regression 62 multivariable analysis 62 linear regressions 62 convergent validity 62 covariates 62 Logistic regression analysis 62 Multivariate analysis 62 chi squared 62 MDRD 61 genetic loci 61 familial clustering 61 intact parathyroid hormone 61 premorbid 61 nonparametric 61 stepwise logistic regression 61 Pearson correlation coefficient 61 metabolic parameters 61 Linear regression 61 pharmacodynamic markers 61 correlation coefficients 61 prognostic factors 61 allele frequencies 61 endophenotypes 60 Bonferroni correction 60 Multivariable logistic regression 60 Subgroup analyzes 60 confidence intervals CIs 60 Kaplan Meier survival 60 binary logistic regression 60 differential gene expression 60 clinicopathological features 60 prognostic indicators 60 subclinical atherosclerosis 60 demographic variables 60 ROC curves 60 cognitive affective 60 interobserver reliability 60 tumor histology 60 laterality 60 perfusion abnormalities 60 chronicity 60 clinicopathologic 59 psychopathological symptoms 59 ANCOVA 59 5 HTTLPR genotype 59 histological subtype 59 gene polymorphisms 59 pairwise 59 neuroanatomical 59 HER2 expression 59 hematopoietic cancers 59 linear regression analyzes 59 clinico pathological 59 prognostic significance 59 generalized linear 59 Kaplan Meier curve 59 Observational studies 59 HOMA IR 59 variance ANOVA 59 dosimetric 59 proportional hazards 59 genetic polymorphisms 59 unmeasured confounders 59 hormone receptor status 59 Pearson correlation coefficients 59 familial aggregation 59 nucleotide substitutions 58 inferential statistics 58 linear regression analysis 58 allelic 58 hierarchical clustering 58 electrophysiologic 58 neurocognitive impairment 58 sociodemographic characteristics 58 Kaplan Meier method 58 genetic aberrations 58 metabolite concentrations 58 susceptibility loci 58 pharmacodynamic parameters 58 univariate analysis 58 epistasis 58 predictive validity 58 quantitative trait loci 58 prognostic variables 58 quantile 58 Socioeconomic status 58 prognostic markers 58 FEV ^ sub 58 unmeasured confounding 58 apolipoproteins 58 psychosocial variables 58 sociodemographic 58 bivariate analysis 58 genetic determinants 58 dichotomized 58 CSF biomarkers 58 Kaplan Meier curves 58 genomic variation 58 multiplicative 58 histopathologic 58 HOXB# 58 affective psychosis 58 Arabidopsis genes 58 glial tumors 58 immunohistochemical 58 biochemical abnormalities 58 gastric carcinoma 57 Correlation coefficients 57 Multivariate analyzes 57 prostate cancer PCa 57 mucinous 57 subscores 57 2D 4D 57 psychiatric morbidity 57 Multivariate 57 antioxidant supplementation 57 oncologic outcomes 57 polygenic 57 genomic alterations 57 miRNA expression 57 sociodemographic factors 57 regression equations 57 ANOVA 57 intraobserver 57 nodal metastases 57 confounding variables 57 comorbidity 57 carotid IMT 57 multivariable adjusted 57 ABCB1 57 observable traits 57 microarray gene expression 57 residual confounding 57 K ras mutations 57 CORE OM 57 Mantel Haenszel 57 transvaginal sonography 57 aetiology 57 anthropometric measures 57 plasma lipid 57 socioeconomic variables 57 proton MR spectroscopy 57 QTLs 57 RRM1 57 diffusion tensor 57 chemosensitivity 57 interindividual variability 57 colorectal carcinogenesis 57 GABRA2 57 monozygotic twins 57 immunohistochemical staining 57 scintigraphic 57 histopathologic findings 57 serum PTH 57 cytologic 57 serum markers 57 Cardiorespiratory fitness 57 bivariate analyzes 57 atherothrombotic 57 inflammatory biomarkers 57 externalizing behaviors 57 confounder 56 logit 56 multivariate regression analysis 56 hyperintense lesions 56 Symptom severity 56 serum cotinine 56 diffusion coefficients 56 immunohistochemical analysis 56 Histopathologic 56 statistically significant correlation 56 artifactual 56 correlational 56 allostatic load 56 hamartomas 56 euthymic patients 56 predictor variables 56 xenobiotic 56 androgen suppression 56 underlying pathophysiology 56 regression analysis 56 intraclass correlation coefficients 56 transgene expression 56 serum biomarkers 56 histone modifications 56 metabolomic profiles 56 F FDG PET 56 HRQL 56 observable behaviors 56 phenotypic variation 56 randomized controlled trials RCTs 56 autonomic dysfunction 56 molecular subtypes 56 leiomyoma 56 syndromal 56 histologic subtypes 56 multivariate analysis 56 abdominal adiposity 56 KRAS mutation status 56 multivariable analyzes 56 HRCT 56 genotypic 56 KRAS status 56 sonographic findings 56 serous ovarian cancer 56 liver metastasis 56 radiographic findings 56 orthologous genes 56 affective psychoses 56 indel 56 neural correlates 56 Neuroticism 56 histologic subtype 56 metabolomic profiling 56 cross sectionally 56 SUVmax 56 HER2 overexpression 56 somatoform disorders 56 biochemical markers 56 EQ 5D 56 Kaplan Meier analysis 56 Supplementary Table 56 prostate cancer CaP 56 metaanalysis 56 genomewide 56 chromosomal rearrangement 56 prospective multicentre 56 pathophysiological mechanisms 56 waist circumference WC 56 uncharacterized genes 56 prognostically 56 urolithiasis 56 karyotypes 56 comorbid disorders 56 5 HTTLPR 56 somatic symptoms 56 Suicidal ideation 56 neuroimaging studies 56 Kruskal Wallis test 56 missense mutations 56 heterozygotes 56 FGFs 56 angiographically 56 System IPSS 56 noncognitive 55 methodological approaches 55 regression coefficient 55 Randomized trials 55 genetic polymorphism 55 Sensitivity analyzes 55 intima media thickness 55 mechanistic studies 55 psychometric properties 55 periprocedural MI 55 posttreatment 55 immunofluorescent 55 gastric cardia 55 methylation patterns 55 bimodal distribution 55 Lp lipoprotein 55 Main Outcome Measures 55 tumor subtypes 55 pairwise comparisons 55 statistically nonsignificant 55 sociodemographics 55 SLC#A# [002] 55 rs# [004] 55 ventilation perfusion 55 lymph node metastasis 55 neurosensory 55 morphometric analysis 55 perseverative 55 breast cancer subtypes 55 surrogate markers 55 HRQOL 55 nomograms 55 HIV tropism 55 VNTR 55 Longitudinal studies 55 recursive partitioning 55 physicochemical properties 55 rCBF 55 nodal metastasis 55 splice variants 55 rs# [002] 55 FDG PET 55 F FDG uptake 55 thyrotropin 55 pressor response 55 WOMAC pain 55 microRNA expression 55 Meta analyzes 55 hyperplastic 55 S. maltophilia 55 antiplatelet therapies 55 colorectal adenoma 55 depressive symptom 55 antiangiogenic therapy 55 correlations 55 transcriptomic 55 PSA kinetics 55 phenotypic differences 55 depressive symptomatology 55 mRNA expression 55 visceral adiposity 55 histopathological 55 probabilistically 55 fractional anisotropy 55 indels 55 atherogenesis 55 methodologic 55 quadratic 55 lymphovascular invasion 55 extramedullary 55 neuropsychological impairments 55 histologic 55 tumorigenicity 55 ratio WHR 55 murine models 55 calculi 55 Likert scale 55 semiquantitative 55 hypericin 55 androgen depletion 55 colorectal adenocarcinoma 55 urodynamic parameters 55 BRCA2 mutation carriers 55 Intermountain Risk Score 55 CVD mortality 55 myocardial dysfunction 55 Regression analysis 55 HRQoL 55 plasma pharmacokinetics 55 Monte Carlo simulations 55 multivariate adjustment 55 prognostic indicator 55 somatic mutations 55 lesional 55 leukocyte telomere length 55 nongenetic 55 nonmelanoma skin cancers 55 bone metabolism 55 symptomatic VTE 55 carotid plaques 55 FDG PET scans 55 atherogenic dyslipidemia 55 intracranial hemorrhage ICH 55 neuropathologic 55 neurocognitive function 55 neurobiological mechanisms 55 interrater reliability 55 confounders 55 PTPN# 55 Figure 1A 55 Charlson comorbidity index 55 telomere lengths 55 lognormal 55 bronchopulmonary dysplasia BPD 55 progesterone receptor PR 55 nonpharmacologic 55 treatment emergent AEs 55 microarray datasets 55 biochemical recurrence 54 retrospective cohort 54 Genotypic 54 plasma proteome 54 fig. S4 54 morphologic 54 platelet activation 54 cranial irradiation 54 pathophysiological 54 heterogeneities 54 thyrotropin levels 54 RNFL thickness 54 molecular biomarker 54 histopathologic diagnosis 54 neuropathological 54 Cronbach alpha 54 TEAEs 54 microsimulation model 54 phenotypic traits 54 albumin excretion rate 54 prognostic marker 54 Cognitive impairment 54 pCR 54 neurodevelopmental outcome 54 protein isoforms 54 postoperative AF 54 Heritability 54 Histologic 54 β1 54 psychobiological 54 QTc prolongation 54 enterotypes 54 behavioral disinhibition 54 morphometry 54 carcinomatosis 54 psychiatric comorbidities 54 variables 54 apo B 54 histologic findings 54 macroeconomic variables 54 ε 54 paralogs 54 glycosylated hemoglobin HbA1c 54 subscale scores 54 multinomial 54 CD# expression [001] 54 psychophysiological 54 SLN biopsy 54 IntroductionThe 54 Sjögren syndrome 54 Comorbidity 54 allelic variation 54 moderately heritable 54 thermodynamic stability 54 Doppler sonography 54 endogenous hormones 54 prostate carcinoma 54 prospective longitudinal 54 Skeletal muscle 54 neoplastic 54 aortic calcification 54 de novo mutations 54 mean ± SEM 54 psychiatric comorbidity 54 FDG PET imaging 54 #q# deletion 54 2D 4D ratio 54 elevated ALT 54 Gaussian distribution 54 prognostic biomarker 54 erection hardness 54 PCNSL 54 neurocognitive functioning 54 exploratory endpoints 54 Subgroup analysis 54 dyssynchrony 54 hyperintensities 54 unmeasured factors 54 dopamine receptor gene 54 neurobiological basis 54 dimensional sonography 54 ADAS cog 54 white matter hyperintensities 54 baseline LDH 54 covariance ANCOVA 54 Multivariable 54 MR spectroscopy 54 genetic variants associated 54 gene loci 54 Personality traits 54 spirometric 54 germline mutations 54 interobserver agreement 54 #S rRNA 54 NIH CPSI 54 subtrochanteric 54 Genetic variation 54 phenotypic expression 54 rs# [001] 54 extrapyramidal symptoms 54 sensitivity specificity 54 perilipin 54 preoperative PSA 54 p# activation 54 cognitive domains 54 apolipoprotein B 54 gonadal hormones 54 coronary stenosis 54 UGT#A# * 54 rho = 54 acetabular dysplasia 54 carotid plaque 54 FDG uptake 54 penetrance 54 monogenic 54 comorbid depression 54 HepG2 cells 54 TIMP 1 54 CHADS2 54 SNP rs# [002] 54 Multivariate analysis revealed 54 serum homocysteine 54 genotypic resistance 54 computed tomographic scans 54 enhanced sonography 54 qRT PCR 54 chromosomal rearrangements 54 microdeletion 54 ependymomas 54 DNA methylation patterns 54 eigenvalue 54 plasma adiponectin 54 seminomas 54 ImmuKnow assay 54 ADAS Cog 54 neuropsychological assessment 54 observable characteristics 54 telomere dysfunction 54 symptomatology 54 PITX2 54 Ki# 54 potentially confounding variables 54 eosinophil count 54 chemoprevention trials 54 socioeconomic status SES 54 Regression analyzes 54 pleiotropy 54 serum lipid 54 virologic responses 54 negative affectivity 54 recurrent venous thromboembolism 54 gadolinium enhanced 54 salivary cortisol 54 pharmacokinetic parameters 54 serum estradiol 54 tumor necrosis 54 Venous thromboembolism 54 histological subtypes 54 NNRTI resistance 54 generalisability 54 aetiological 54 parkinsonism 54 pre malignant lesions 53 coronary stenoses 53 heritable variation 53 ultrasonographic 53 RNFL 53 atherogenic 53 protein tyrosine phosphatase 53 Depressive symptoms 53 arterial thickening 53 NMIBC 53 morphological abnormalities 53 transient elastography 53 CHEK2 53 gene expression profiles 53 Main Outcome Measure 53 comorbid conditions 53 obstructive CAD 53 Kaplan Meier 53 PCa 53 emotional dysregulation 53 perturbation theory 53 elevated homocysteine 53 microvessel density 53 MMSE score 53 endometrial carcinoma 53 ABCB1 gene 53 developmental trajectories 53 adnexal mass 53 extensive metabolizers 53 BPS IC 53 distant metastasis 53 pulmonary nodules 53 chromatograms 53 metabolic syndrome MetS 53 epigenetic markers 53 proteomes 53 imply causality 53 body fatness 53 immunostaining 53 albumin excretion 53 chest radiographs 53 PON1 gene 53 colonoscopic 53 mammographic density 53 Logistic regression models 53 adverse perinatal 53 linkage disequilibrium 53 symptomology 53 interindividual 53 Fig. 3b 53 androgen signaling 53 biologic pathways 53 glaucomatous 53 subscales 53 pleiotropic effects 53 neurophysiologic 53 prospective multicenter study 53 endometrial thickness 53 P cadherin 53 LDL HDL 53 stratifying patients 53 risk reducing salpingo 53 Tasigna prolongs 53 socioeconomic deprivation 53 MTT assay 53 quantitative EEG 53 conventional angiography 53 serum PSA 53 haemodynamic 53 splice junctions 53 homozygosity 53 hallux limitus 53 MLH1 53 FDG-PET/CT 53 anatomic structures 53 psychosocial distress 53 interannual variability 53 statistical correlations 53 physiologic parameters 53 plain radiographs 53 cortical activation 53 evolvability 53 schizophreniform disorder 53 APOE e4 53 functional gastrointestinal disorders 53 gene amplification 53 testicular tumors 53 Western blotting 53 T2DM 53 SCr 53 histopathologic examination 53 adipokines 53 Mechanistic studies 53 ECLS 53 probands 53 CYP#D# genotype 53 regression coefficients 53 categorical variables 53 potential confounders 53 HAQ DI 53 viral kinetics 53 cystatin 53 phenotypes 53 multivariable regression 53 inhomogeneities 53 prostate carcinogenesis 53 glucose abnormalities 53 microscopic colitis 53 metaplasia 53 thromboembolic disease 53 induced sputum 53 renal cysts 53 DSM IV diagnoses 53 pharmacodynamic endpoints 53 synovial cells 53 Genetic variants 53 #S rRNA gene 53 metabolic dysfunction 53 recurrent miscarriage 53 deCODE BreastCancer TM 53 physiologic mechanisms 53 haematologic 53 microarray experiments 53 nitrotyrosine 53 serum BDNF 53 thiopurine 53 developmental neurotoxicity 53 anatomical landmarks 53 affective disorders 53 β = 53 plexiform 53 astrocytic 53 observational cohort 53 parasitaemia 53 chemometrics 53 #S rDNA 53 Genetic predisposition 53 platelet reactivity 53 polymorphisms 53 histologies 53 fetal malformations 53 nucleated cells 53 insulin resistance HOMA IR 53 somatoform disorder 53 chromatogram 53 carcinoembryonic antigen 53 genomewide association studies 53 symptom exacerbation 53 EORTC QLQ C# 53 apparent diffusion coefficient 53 lipid abnormalities 53 quasispecies 53 parous women 53 primary aldosteronism 53 gene polymorphism 53 nanomolar 53 Duration Gap 53 leukocyte counts 53 microvascular complications 53 functional polymorphism 53 monozygotic 53 cerebral microbleeds 53 underestimations 53 dose proportionality 53 generalisable 53 dimensional ultrasonography 53 poststroke depression 53 ABL1 53 Scale Cognitive Subscale 53 adjuvant therapies 53 atherothrombotic disease 53 Chlamydia trachomatis infection 53 Logistic regression analyzes 53 subthreshold 53 elevated LDH 53 pathogenic mechanisms 53 fraternal twin pairs 53 miRs 53 haplotypes 53 CHI#L# 53 tHcy 53 weakly correlated 53 fluoroquinolone resistance 53 graphene electrons 53 mitochondrial DNA mtDNA 53 MDRD equation 53 Cytogenetic 53 carcinoids 53 urothelial carcinoma 53 variant allele 53 psychodynamic psychotherapy 52 nonpsychiatric 52 TMPRSS2 ERG fusion 52 VKORC1 52 meta analytic review 52 EBV infection 52 left ventricular diastolic 52 tolerability pharmacokinetics 52 Haptoglobin 52 chromosome aberrations 52 CHD mortality 52 prothrombotic 52 T1a 52 Secondary efficacy endpoints 52 androgen deficiency 52 pharmacodynamic effects 52 Bayesian inference 52 Phenotypic 52 posttranslational modifications 52 symptom severity 52 IPAH 52 cortical regions 52 NIHSS score 52 aortic stiffness 52 epithelial tumors 52 CYP#D# gene 52 autocorrelation 52 lymphocyte subsets 52 chromosomal regions 52 computational algorithms 52 quantitative computed tomography 52 sensory modalities 52 axial length 52 hippocampal volume 52 lethal arrhythmias 52 intraclass correlation coefficient 52 CIN2 + 52 pharmacodynamic PD 52 carotid atherosclerosis 52 voxel 52 renal tumors 52 cystatin C 52 psychosocial functioning 52 postoperative delirium 52 fasting insulin 52 plasma cortisol 52 aminotransferase levels 52 regressions 52 supratentorial 52 unconjugated 52 MetS 52 NRF2 gene 52 thyroid carcinoma 52 Female Sexual Function 52 gastric adenocarcinoma 52 postoperative mortality 52 comorbidities 52 kurtosis 52 PIB PET 52 comorbid anxiety 52 etiological 52 linear regression 52 #F FDG PET 52 parkinsonian 52 dichotomous variables 52 gene APOE 52 patient subpopulations 52 PTEN mutations 52 cardiometabolic risk 52 cellularity 52 assortative mating 52 hypoperfusion 52 RT qPCR 52 perfusion defect 52 EGFR HER2 52 EGFR expression 52 renal cortical 52 nucleosome positioning 52 EEG recordings 52 hypochondriasis 52 Prognostic factors 52 multivariate 52 enzyme immunoassay EIA 52 causative mutations 52 ovarian hormones 52 electroencephalographic 52 β blockers 52 posttraumatic 52 KRAS mutations 52 chromosomal alterations 52 genome rearrangements 52 BEXXAR Therapeutic Regimen 52 substrate specificity 52 chromosomal aberrations 52 NHAMCS 52 MRSA isolates 52 putative biomarkers 52 thalamic 52 phylogenetic analyzes 52 ADCS ADL 52 CTEPH 52 κ 52 airway hyperresponsiveness 52 neurocognitive deficits 52 ultrastructural 52 endogenous estrogen 52 Wechsler Adult 52 LV dysfunction 52 avoidant personality disorder 52 enantiomers 52 modifier genes 52 lymphoproliferative disorders 52 cardiac repolarization 52 bone scintigraphy 52 CNTNAP2 52 quantitative RT PCR 52 subgroup analyzes 52 lymphocytic 52 myeloproliferative diseases 52 PCWP 52 vimentin 52 Baseline characteristics 52 hedonic regression 52 hyperalgesia 52 subcellular localization 52 silent myocardial ischemia 52 circadian genes 52 likelihoods 52 ALSFRS R 52 comorbid psychiatric 52 amygdala reactivity 52 highly heritable 52 intraventricular 52 BMI z 52 ConclusionThis 52 tumor biopsies 52 highest tertile 52 #p# [003] 52 CD# expression [002] 52 atherosclerotic vascular disease 52 perceivers 52 hemorrhagic complications 52 GBA mutations 52 nonfatal MI 52 abnormal lipid 52 clefting 52 crustal thickness 52 SMAD4 52 grade interpolation 52 anthropometric measurements 52 impaired glucose metabolism 52 SSc 52 H#K#me# 52 mTOR inhibitors 52 APOE ε4 52 serologically active patients 52 gastric carcinomas 52 probabilistic modeling 52 alkaline phosphatase ALP 52 wavelet transform 52 estrogen receptor ER 52 hypercalciuria 52 CT perfusion 52 stochasticity 52 genetic heterogeneity 52 FeNO 52 microstructural 52 tumor perfusion 52 RRs 52 genetic susceptibilities 52 BMI waist circumference 52 syndromic 52 Correlations 52 TOP2A 52 plasma leptin 52 amino acid substitutions 52 hyper IgE syndrome 52 myofascial trigger 52 fungal genomes 52 tamoxifen metabolism 52 nucleolar 52 hepatic fibrosis 52 myocardial perfusion 52 Leydig cell 52 EGFR mutation status 52 adjuvant systemic 52 plasma lipoprotein 52 Alternative splicing 52 non pharmacological interventions 52 Clusterin 52 DCE MRI 52 QSAR models 52 compulsive hoarding syndrome 52 geomorphological 52 independent prognostic marker 52 internalizing disorders 52 psychosocial stressors 52 pharmacokinetic characteristics 52 human leukocyte antigens 52 spontaneous regression 52 transcriptomes 52 Fig. 3a 52 noncardiac 52 diagnostic biomarker 52 esophageal squamous cell carcinoma 52 ascertainment bias 52 hepatic arterial 52 physico chemical 52 hyperintensity 52 homology modeling 52 Immunohistochemical 52 hepatocellular carcinomas 52 Socio demographic 52 colocalization 52 liver transplant recipients 52 prespecified secondary 52 cosmological models 52 p = .# [002] 52 microsatellite instability 52 PNH patients 52 oncogenic transformation 52 core needle biopsies 52 myocardial viability 52 vertebral subluxation 52 florbetaben 52 constipation predominant IBS 52 PON1 52 antiangiogenic agents 52 postdischarge 52 pathogenic mutations 52 Heterogeneity 52 posttest 52 proinflammatory mediators 52 Probabilistic 52 MGUS 52 salivary proteins 52 STRATEGY FOR AN OPEN 52 Gene Ontology 52 Cystatin C 52 Cardiotoxicity 52 hematological parameters 52 pharmacokinetic interactions 52 stereochemical 52 mitochondrial gene 52 schizotypal traits